Health

Coronavirus US: NIH clinical trial for remdesivir and baricitinib for COVID-19

Coronavirus US: NIH clinical trial for remdesivir and baricitinib for COVID-19.

NIH clinical trial tests remdesivir plus anti-inflammatory drug baricitinib for COVID-19

(NIH/National Institute of Allergy and Infectious Diseases) A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for COVID-19 has begun. The trial is now enrolling hospitalized adults with COVID-19 in the United States. The trial is expected to open at approximately 100 US and international sites. Investigators currently anticipate enrolling more than 1,000 participants. The National Institute of Allergy and Infectious Diseases is sponsoring the trial.

Read More…….
EurekAlert!, the online, global news service operated by AAAS, the science society,